| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/23/2009 | WO2008082512A3 Focused beam reflectance measurement to optimize desalter performance and reduce downstream fouling |
| 04/23/2009 | WO2007138577A3 Methods of generating a neural tissue using muscle-derived cells |
| 04/23/2009 | WO2007138574A3 Monitoring responsiveness to and screening for therapeutic compounds that modulat composition and structure of cell membranes |
| 04/23/2009 | WO2007127002A3 Protein markers of responsiveness to type iii receptor tyrosine kinase inhibitors |
| 04/23/2009 | WO2007116408A3 Pluripotent stem cells characterized by expression of germline specific genes |
| 04/23/2009 | WO2007053480A3 Protein demethylases comprising a jmjc domain |
| 04/23/2009 | WO2007047458A3 Diagnosis and monitoring of chronic renal disease using ngal |
| 04/23/2009 | WO2007041621A3 Hybridization assisted nanopore sequencing |
| 04/23/2009 | WO2007024940A3 Mitochondrial localization of muc1 |
| 04/23/2009 | WO2007022074A3 Assay particles and methods of use |
| 04/23/2009 | WO2007018897A3 Method for processing chemistry and coagulation test samples in a laboratory workcell |
| 04/23/2009 | WO2007016740A8 Water analysis using a photoelectrochemical method |
| 04/23/2009 | WO2007013997A3 Inhibition of the raf/mek/p-erk pathway for treating cancer |
| 04/23/2009 | WO2007002677A3 Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease |
| 04/23/2009 | WO2007002510A3 A system and method to obtain oligo-peptides with specific high affinity to query proteins |
| 04/23/2009 | WO2007002037A3 Trace sampling |
| 04/23/2009 | WO2006135886A3 Compositions and methods for treating and diagnosing cancer |
| 04/23/2009 | WO2006133333A3 Stimulation of pancreatic b cell proliferation |
| 04/23/2009 | WO2006133191A3 Methods and apparatus for performing retention-time matching |
| 04/23/2009 | WO2006127704A3 Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia |
| 04/23/2009 | WO2006124575A3 An Electromagnetic Probe Device |
| 04/23/2009 | WO2006122312A3 Methods of testing using a microfluidic cassette |
| 04/23/2009 | WO2006119406A3 Compositions and methods for increasing osteoblast cell differentiation and bone generation |
| 04/23/2009 | WO2006116455A3 System for genetic surveillance and analysis |
| 04/23/2009 | WO2006110561A3 Methods and compositions for identifying chemical or biological agents using multiplexed labeling and colocalization detection |
| 04/23/2009 | WO2006107387A3 Wound treatment device for photodynamic therapy and method of using same |
| 04/23/2009 | WO2006102070A3 Sclerostin and the inhibition of wnt signaling and bone formation |
| 04/23/2009 | WO2006099623A3 Methods and compositions to diagnose disease using concatenated oligopeptide standard |
| 04/23/2009 | WO2006099518A3 Capacitance-based sensing of molecular absorbates on the surface of single walled carbon nanotubes |
| 04/23/2009 | WO2006078776A3 Inhibitors and methods of treatment of cardiovascular diseases, and methods for identifying inhibitors |
| 04/23/2009 | WO2006076467A3 Treatment of pre-eclampsia in pregnant women using targeted apheresis |
| 04/23/2009 | WO2006071843A3 Biomarkers for breast cancer |
| 04/23/2009 | WO2006052821A3 Compositions and methods for treatment of protein misfolding and protein aggregation diseases |
| 04/23/2009 | WO2006046229A3 A detector comprising a membrane perturbation - detecting polymer and functional membrane fragments |
| 04/23/2009 | WO2006042218A3 Device and method for the determination of dry weight by continuous measurement of resistance and calculation of circumference in a body segment using segmental bioimpedance analysis |
| 04/23/2009 | WO2006031583A3 Methods and compositions for measuring canine bnp and uses thereof |
| 04/23/2009 | WO2006001896A3 A universal gene chip for high throughput chemogenomic analysis |
| 04/23/2009 | WO2005121179A3 Transferrin receptor antibodies |
| 04/23/2009 | WO2005094476A3 High throughput electrophysiology system |
| 04/23/2009 | WO2005089415A3 Stabilization of self-assembled monolayers |
| 04/23/2009 | WO2005077084A3 Krüppel-like transcriptional factor klf4/gklf and uses thereof |
| 04/23/2009 | WO2004028479A9 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/23/2009 | WO2003025192A3 Membrane transportable fluorescent substrates |
| 04/23/2009 | US20090105965 Method for determining the ignitability of fuel with an unknown fuel quality |
| 04/23/2009 | US20090105962 Methods and systems for identifying molecular pathway elements |
| 04/23/2009 | US20090105961 Methods of nucleic acid identification in large-scale sequencing |
| 04/23/2009 | US20090105960 Device for supporting diagnosis of a cancer and a device for predicting an effects of anthracycline anticancer drugs |
| 04/23/2009 | US20090105959 System and method for identification of individual samples from a multiplex mixture |
| 04/23/2009 | US20090105958 Method for skeletal maturity determination |
| 04/23/2009 | US20090105454 Prophylactic/therapeutic agent for cancer |
| 04/23/2009 | US20090105453 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents |
| 04/23/2009 | US20090105452 Non-fluorescent quencher compounds and biomolecular assays |
| 04/23/2009 | US20090105286 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors |
| 04/23/2009 | US20090105187 Methods of treating lentivirus infection |
| 04/23/2009 | US20090105136 NPY Y2 Agonist for Use as Therapeutic Agent for Disease Accompanied by Diarrhea |
| 04/23/2009 | US20090105133 Gamma-Delta T Cell Receptors |
| 04/23/2009 | US20090105128 Cannabinoid receptor targeted agent |
| 04/23/2009 | US20090105116 Polypeptide Ligands Containing Linkers |
| 04/23/2009 | US20090105093 Biomolecule substrate, and test and diagnosis methods and apparatuses using the same |
| 04/23/2009 | US20090105086 Methods of selecting internalizing antibodies |
| 04/23/2009 | US20090104717 System to Reduce Incubation Time in Immunological Testing Using Enhanced Microwaves |
| 04/23/2009 | US20090104716 Target substance detecting element, target substance detecting apparatus, and target substance detecting method |
| 04/23/2009 | US20090104715 Method for mixing two or more types of liquids in porous carrier |
| 04/23/2009 | US20090104714 Visual glucose sensor and methods of use thereof |
| 04/23/2009 | US20090104713 Phenobarbital derivatives useful in immunoassay |
| 04/23/2009 | US20090104712 Hepatitis b pre-s2 nucleic acid |
| 04/23/2009 | US20090104708 Human laminin receptor crystal and uses thereof |
| 04/23/2009 | US20090104707 Analyte detection with magnetic sensors |
| 04/23/2009 | US20090104706 Cytokine receptor modulators, method of identifying same, and method of modulating cytokine receptors activity with same |
| 04/23/2009 | US20090104705 Ascorbic acid conjugates |
| 04/23/2009 | US20090104703 Nucleic Acids Encoding Proteins Involved in Sensory Transduction |
| 04/23/2009 | US20090104693 a gene encoding the blood group Pk (Gb3) synthase, termed alpha 4Gal-T1, probes to the DNA encoding alpha 4Gal-T1, DNA constructs comprising DNA encoding alpha 4Gal-T1 |
| 04/23/2009 | US20090104684 Diagnosis of carcinomas |
| 04/23/2009 | US20090104651 Screening process for antibacterial agents |
| 04/23/2009 | US20090104650 Infectious diseases testing of menstrual fluid, endometrial/menstrual cells, amniotic fluid, umbilical cord blood or other samples |
| 04/23/2009 | US20090104642 Novel ubiquitin ligases as therapeutic targets |
| 04/23/2009 | US20090104641 Providing blood specimen, exposing to cyclodextrin modified reagent, detecting electric current produced by reaction of hemoglobin and electron mediator under potentiostatic condition, calculate concentration of hemoglobin |
| 04/23/2009 | US20090104639 Biomarkers for motor neuron disease |
| 04/23/2009 | US20090104636 Quantitative analysis of a biological sample of unknown quantity |
| 04/23/2009 | US20090104634 One-step immunoassays exhibiting increased sensitivity and specificity |
| 04/23/2009 | US20090104633 Kit for Highly Sensitive Detection Assays |
| 04/23/2009 | US20090104632 Modified two-step immunoassay exhibiting increased sensitivity |
| 04/23/2009 | US20090104631 Psca: prostate stem cell antigen and uses thereof |
| 04/23/2009 | US20090104630 Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 ligand/CD 154, A CD4+T cell equivalent |
| 04/23/2009 | US20090104629 Use of biomarkers of alzheimer's disease for diagnostic tests and drug screening |
| 04/23/2009 | US20090104628 Method for quantifying phosphokinase activity on proteins |
| 04/23/2009 | US20090104627 Method for determination of enzymatic activity |
| 04/23/2009 | US20090104626 Methods of isolating bipotent hepatic progenitor cells |
| 04/23/2009 | US20090104625 Homogeneous immunoassays for multiple allergens |
| 04/23/2009 | US20090104624 Methods and kits for detecting ita in a biological sample |
| 04/23/2009 | US20090104623 Compositions for controlling hair growth |
| 04/23/2009 | US20090104622 Extracellular/Epidermal Growth Factor Like Protein |
| 04/23/2009 | US20090104618 Diagnosing high grade ductal carcinoma (mammary glands) in situ (DCIS) by determining the level of psoriasin gene expression in a sample |
| 04/23/2009 | US20090104617 Diagnostic and Prognostic Tests |
| 04/23/2009 | US20090104614 Quantitative molecular probes |
| 04/23/2009 | US20090104609 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| 04/23/2009 | US20090104606 Late gestation lung genes, fragments and uses thereof |
| 04/23/2009 | US20090104605 Diagnosis of sepsis |
| 04/23/2009 | US20090104603 Tissue Carbohydrate Compositions and Analysis Thereof |
| 04/23/2009 | US20090104602 Diagnosis of Tuberculosis |